Abbott’s STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories
Date: January 18, 2012
Abbott Park (NYSE: ABT) — Abbott announced today that the U.S. Food and Drug Administration (FDA) will begin implementing Abbott’s STARLIMS® software-based laboratory information management system.
STARLIMS LIMS software will be used to manage complex processes and the analysis of the vast amounts of information generated by FDA laboratories.
As part of a master agreement with Dovèl Technologies, a company that provides high-end software applications to government organizations, the FDA’s Office of Regulatory Affairs (ORA) will begin deploying LIMS solutions from STARLIMS, designed to enhance testing of food and drug chemistries, devices, forensics material and microbiology samples. The ORA operates mainly five types of laboratories in 14 separate locations. The LIMS solution will provide the needed capability to manage the analytical workflow operations in ORA labs for approximately 825 users supporting sample accountability, data analysis, document control, report generation, and other lab operation functions.
“We’re looking forward to working on this important initiative,” said Isaac Friedman, head of Abbott’s STARLIMS business. “STARLIMS has a successful track record in implementing web-based LIMS for life sciences organizations, public health laboratories and a number of federal agencies.”
Based in Hollywood, Fla., Abbott’s STARLIMS business (www.starlims.com) is a leading provider of laboratory information management systems, with more than 20 years of LIMS experience. STARLIMS products help improve the reliability of laboratory sampling processes, support compliance with domestic and international regulations and industry standards, and provide comprehensive reporting, monitoring and analysis capabilities. STARLIMS software is used for quality assurance and control, testing and monitoring, and research and development in government, manufacturing and life sciences organizations. With 12 development and support centers across the globe, STARLIMS serves customers in more than 40 countries.
Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.